Immuno-rna-constructs

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/113 (2010.01) A61K 31/7105 (2006.01) A61K 35/12 (2006.01) A61K 47/48 (2006.01) A61P 35/00 (2006.01) C12N 15/11 (2006.01) C07H 21/00 (2006.01) C07K 16/28 (2006.01)

Patent

CA 2633776

Subject of the invention is a compound, consisting of a targeting moiety which specifically binds to a disease related cell surface marker, a nucleic acid which specifically induces cell death and a linker, wherein the linker covalently links the targeting moiety to the nucleic acid. Subject of the invention are also medicaments comprising the compound and their use as a medicament for the treatment of diseases, including proliferative diseases.

L'invention se rapporte à un composé comprenant une fraction de ciblage qui se lie de manière spécifique à un marqueur de surface cellulaire dont la présence est liée à une maladie, un acide nucléique qui induit une mort cellulaire de manière spécifique, ainsi qu'un lieur. Selon l'invention, ce lieur établit une liaison covalente entre la fraction de ciblage et l'acide nucléique. Cette invention concerne en outre des médicaments qui comprenent ledit composé, ainsi que leur utilisation pour traiter des maladies parmi lesquelles figurent des maladies prolifératives.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Immuno-rna-constructs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immuno-rna-constructs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immuno-rna-constructs will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1794845

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.